Atlas Trials

Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models

Clinical trial NCT04646837 · UNKNOWN

Trial details

NCT number
NCT04646837
Sponsor
Peking Union Medical College Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2021-05-01
Primary completion
2024-05-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.